About V-Edit
V-Edit is a company based in Bengaluru (India) founded in 2024 by Debabrata Jana. It operates as a B2B. V-Edit offers products and services including Genome Editing Services and Cell Engineering Services. V-Edit operates in a competitive market with competitors including Beam Therapeutics, eGenesis, Korro Bio, Metagenomi and Prime Medicine, among others.
- Headquarter Bengaluru, India
- Founders Debabrata Jana
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name V-Edit Life Sciences Private Limited
- Jurisdiction Bangalore North, Karnataka, India
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of V-Edit
V-Edit offers a comprehensive portfolio of products and services, including Genome Editing Services and Cell Engineering Services.
Provides CRISPR-based genome editing for genetic research applications.
Offers cell line development and engineering for biopharma needs.
Funding Insights of V-Edit
Detailed funding history for V-Edit
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by V-Edit
Investment portfolio details for V-Edit
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - V-Edit
Detailed financials for V-Edit
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
V-Edit Comparisons
Peer comparison for V-Edit
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of V-Edit
V-Edit operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Beam Therapeutics, eGenesis, Korro Bio, Metagenomi and Prime Medicine, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of gene therapy using CRISPR base editing to treat diseases
|
|
| Locked | Locked | Locked |
Gene transplantation platform for humanizing pig cells is developed.
|
|
| Locked | Locked | Locked |
RNA-editing technologies are provided for precision medicine applications.
|
|
| Locked | Locked | Locked |
Next-generation gene editing tools are developed for drug enhancement.
|
|
| Locked | Locked | Locked |
Genetic therapies for diseases are developed using prime editing technology.
|
|
| Locked | Locked | Locked |
A CRISPR-based gene-editing platform is developed for therapeutic applications.
|
Detailed competitors of V-Edit
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on V-Edit
Complete news archive for V-Edit
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about V-Edit
V-Edit was founded in 2024.
V-Edit is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Debabrata Jana is the current CEO of V-Edit. They have also founded this company.
V-Edit Life Sciences specializes in genome editing and cell engineering, providing tailored CRISPR-based services for genetic research and biopharma applications. They focus on reliable solutions for cell line development and stem cell therapy, empowering advancements in biotechnology. Located in Bangalore and Bidadi, India, they serve clients in the healthcare sector through collaborative and efficient processes.
V-Edit's top competitors include eGenesis, Tessera Therapeutics and Korro Bio.
V-Edit offers Genome Editing Services and Cell Engineering Services.